3/AFiling Date: Sep 4, 2026

Eli Lilly

Initial Statement of Beneficial Ownership

View SEC Filing
ACC: 0002096888-26-000006
Total Value$0
Trades2
Insiders1

Transaction Details

Brown Adrienne S
EVP, President LLY Imm·Direct
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After7.05K
Footnotes ▸

Corrects the number of shares previously reported to account for additional shares that were unintentionally omitted from the original Form 3 filing, and subsequent Forms 4.

Brown Adrienne S
EVP, President LLY Imm·Direct
Restricted Stock UnitDerivative
Shares0
Price-
Total Value$0
ExpiresFeb 16, 2026
Holding Only
Footnotes ▸

Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Post-Transaction Holdings

Brown Adrienne S · EVP, President LLY Imm
SecuritySharesChange
Common Stock7.05K-
Restricted Stock Unit--
Original SEC Filing Textexpand_more
=== SEC Form 3/A — Statement of Changes in Beneficial Ownership === Document Type: 3/A Period of Report: 2025-11-07 --- Issuer --- Name: ELI LILLY & Co (LLY) CIK: 0000059478 --- Reporting Owner --- Name: Brown Adrienne S CIK: 0002096888 Role: Officer (EVP, President LLY Imm) --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) Footnotes: [F1] Corrects the number of shares previously reported to account for additional shares that were unintentionally omitted from the original Form 3 filing, and subsequent Forms 4. [Holding #2] Security: Restricted Stock Unit Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. [Holding #3] Security: Restricted Stock Unit Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. [Holding #4] Security: Restricted Stock Unit Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. [Holding #5] Security: Restricted Stock Unit Ownership: D (Direct) Footnotes: [F2] Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. --- Footnotes (Complete Index) --- F1: Corrects the number of shares previously reported to account for additional shares that were unintentionally omitted from the original Form 3 filing, and subsequent Forms 4. F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. --- Signature --- /s/ /s/ Jonathan Groff for Adrienne Brown, pursuant to authorization on file (2026-09-04)

keid analysis is for reference only and does not constitute investment advice.